Video Experimental Relacionado
Updated: Jul 6, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
La enfermedad de Alzheimer es la enfermedad de Alzheimer
Kaj Blennow1, Mony J de Leon, Henrik Zetterberg
1Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgren's University Hospital, Mölndal, Sweden. kaj.blennow@neuro.gu.se
Lancet (London, England)
|August 1, 2006
Resumen
La enfermedad de Alzheimer, una demencia común, involucra placas beta amiloide y enredos tau. Sus causas complejas, especialmente en formas esporádicas, involucran el envejecimiento, la genética y los factores ambientales, lo que requiere más investigación para tratamientos efectivos.
Área de la Ciencia:
- Neurología Neurología.
- Biología Molecular Biología Molecular
- Genética La genética.
Sus antecedentes:
- La enfermedad de Alzheimer (EA) es la principal causa de demencia.
- Las principales características patológicas incluyen placas de beta amiloide (Abeta) y ovillos de tau hiperfosforilados.
- La comprensión de la patogénesis de la EA está avanzando, revelando una complejidad significativa.
Objetivo del estudio:
- Revisar la epidemiología, genética, patogénesis, diagnóstico y tratamiento de la enfermedad de Alzheimer.
- Para resaltar los desarrollos recientes y las controversias en curso en la investigación de la EA.
- Para diferenciar entre las formas familiares y esporádicas de la enfermedad de Alzheimer.
Principales métodos:
- Revisión de la literatura existente sobre la enfermedad de Alzheimer.
- Análisis de la patogénesis molecular, incluyendo Abeta y tau.
- Examen de los factores de riesgo genéticos y ambientales para el Alzheimer esporádico.
Principales resultados:
- La EA familiar es rara, de inicio temprano y está relacionada con las mutaciones del gen APP y de la presenilina que afectan el metabolismo de Abeta.
- La EA esporádica es común, con una etiología desconocida atribuida al envejecimiento, las interacciones genéticas y ambientales.
- La heterogeneidad de la EA esporádica complica la comprensión y el desarrollo de tratamientos.
Conclusiones:
- La patogénesis de la enfermedad de Alzheimer es compleja, ya que involucra factores genéticos y ambientales.
- La investigación adicional es crucial para desentrañar las causas de la enfermedad de Alzheimer esporádica y desarrollar terapias dirigidas.
- Una comprensión completa de la enfermedad de Alzheimer, desde los mecanismos moleculares hasta los factores de riesgo, es esencial para el progreso clínico.
Videos de Conceptos Relacionados
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...